TY - JOUR
T1 - Improved 5-year prediction of all-cause mortality by coronary CT angiography applying the CONFIRM score
AU - Deseive, Simon
AU - Shaw, Leslee J.
AU - Min, James K.
AU - Achenbach, Stephan
AU - Andreini, Daniele
AU - Al-Mallah, Mouaz H.
AU - Berman, Daniel S.
AU - Budoff, Matthew J.
AU - Callister, Tracy Q.
AU - Cademartiri, Filippo
AU - Chang, Hyuk Jae
AU - Chinnaiyan, Kavitha
AU - Chow, Benjamin J.W.
AU - Cury, Ricardo C.
AU - DeLago, Augustin
AU - Dunning, Allison M.
AU - Feuchtner, Gudrun
AU - Kaufmann, Philipp A.
AU - Kim, Yong Jin
AU - Leipsic, Jonathon
AU - Marques, Hugo
AU - Maffei, Erica
AU - Pontone, Gianluca
AU - Raff, Gilbert
AU - Rubinshtein, Ronin
AU - Villines, Todd C.
AU - Hausleiter, Jörg
AU - Hadamitzky, Martin
N1 - Publisher Copyright:
© 2016 Published on behalf of the European Society of Cardiology.
PY - 2017/3/1
Y1 - 2017/3/1
N2 - Aims To investigate the long-term performance of the CONFIRM score for prediction of all-cause mortality in a large patient cohort undergoing coronary computed tomography angiography (CCTA). Methods and results Patients with a 5-year follow-up from the international multicentre CONFIRM registry were included. The primary endpoint was all-cause mortality. The predictive value of the CONFIRM score over clinical risk scores (Morise, Framingham, and NCEP ATP III score) was studied in the entire patient population as well as in subgroups. Improvement in risk prediction and patient reclassification were assessed using categorical net reclassification index (NRI) and integrated discrimination improvement (IDI). During a median follow-up period of 5.3 years, 982 (6.5%) of 15 219 patients died. The CONFIRM score outperformed the prognostic value of the studied three clinical risk scores (c-indices: CONFIRM score 0.696, NCEP ATP III score 0.675, Framingham score 0.661, Morise score 0.606; c-index for improvement CONFIRM score vs. NCEP ATP III score 0.650, P < 0.0001). Application of the CONFIRM score allowed reclassification of 34% of patients when compared with the NCEP ATP III score, which was the best clinical risk score. Reclassification was significant as revealed by categorical NRI (0.06 with 95% CI 0.02 and 0.10, P = 0.005) and IDI (0.013 with 95% CI 0.01 and 0.015, P < 0.001). Subgroup analysis revealed a comparable performance in a variety of patient subgroups. Conclusions The CONFIRM score permits a significantly improved prediction of mortality over clinical risk scores for >5 years after CCTA. These findings are consistent in a large variety of patient subgroups.
AB - Aims To investigate the long-term performance of the CONFIRM score for prediction of all-cause mortality in a large patient cohort undergoing coronary computed tomography angiography (CCTA). Methods and results Patients with a 5-year follow-up from the international multicentre CONFIRM registry were included. The primary endpoint was all-cause mortality. The predictive value of the CONFIRM score over clinical risk scores (Morise, Framingham, and NCEP ATP III score) was studied in the entire patient population as well as in subgroups. Improvement in risk prediction and patient reclassification were assessed using categorical net reclassification index (NRI) and integrated discrimination improvement (IDI). During a median follow-up period of 5.3 years, 982 (6.5%) of 15 219 patients died. The CONFIRM score outperformed the prognostic value of the studied three clinical risk scores (c-indices: CONFIRM score 0.696, NCEP ATP III score 0.675, Framingham score 0.661, Morise score 0.606; c-index for improvement CONFIRM score vs. NCEP ATP III score 0.650, P < 0.0001). Application of the CONFIRM score allowed reclassification of 34% of patients when compared with the NCEP ATP III score, which was the best clinical risk score. Reclassification was significant as revealed by categorical NRI (0.06 with 95% CI 0.02 and 0.10, P = 0.005) and IDI (0.013 with 95% CI 0.01 and 0.015, P < 0.001). Subgroup analysis revealed a comparable performance in a variety of patient subgroups. Conclusions The CONFIRM score permits a significantly improved prediction of mortality over clinical risk scores for >5 years after CCTA. These findings are consistent in a large variety of patient subgroups.
UR - http://www.scopus.com/inward/record.url?scp=85022333316&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85022333316&partnerID=8YFLogxK
U2 - 10.1093/ehjci/jew195
DO - 10.1093/ehjci/jew195
M3 - Article
C2 - 28363203
AN - SCOPUS:85022333316
SN - 2047-2404
VL - 18
SP - 286
EP - 293
JO - European heart journal cardiovascular Imaging
JF - European heart journal cardiovascular Imaging
IS - 3
ER -